Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and extracting subtle biomarker signatures from multiple data modalities and sources remains challenging.

The cloud-based and decentralized SOPHiA DDM™ Platform integrates data and algorithms, driving valuable insights to uncover biomarkers, identify requirement-matching cohorts, enhance clinical trial performance, and streamline the development of new drugs.

Discover data-driven solutions optimized for each stage of your drug development journey.